Abstract
Drug-drug interactions (DDIs) are a major contributing factor for unexpected adverse drug events (ADEs). However, few of knowledge resources cover the severity information of ADEs that is critical for prioritizing the medical need. The objective of the study is to develop and evaluate a Semantic Web-based approach for mining severe DDI-induced ADEs. We utilized a normalized FDA Adverse Event Report System (AERS) dataset and performed a case study of three frequently prescribed cardiovascular drugs: Warfarin, Clopidogrel and Simvastatin. We extracted putative DDI-ADE pairs and their associated outcome codes. We developed a pipeline to validate the associations using ADE datasets from SIDER and PharmGKB. We also performed a cross validation using electronic medical records (EMR) data. We leveraged the Common Terminology Criteria for Adverse Event (CTCAE) grading system and classified the DDI-induced ADEs into the CTCAE in the Web Ontology Language (OWL). We identified and validated 601 DDI-ADE pairs for the three drugs using the validation pipeline, of which 61 pairs are in Grade 5, 56 pairs in Grade 4 and 484 pairs in Grade 3. Among 601 pairs, the signals of 59 DDI-ADE pairs were identified from the EMR data. The approach developed could be generalized to detect the signals of putative severe ADEs induced by DDIs in other drug domains and would be useful for supporting translational and pharmacovigilance study of severe ADEs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tatonetti, N.P., Fernald, G.H., Altman, R.B.: A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J. Am. Med. Inf. Assoc. JAMIA 19(1), 79–85 (2012)
Daly, A.K.: Pharmacogenomics of adverse drug reactions. Genome Med. 5(1), 5 (2013)
Wang, L., McLeod, H.L., Weinshilboum, R.M.: Genomics and drug response. New Engl. J. Med. 364(12), 1144–1153 (2011)
Phillips, K.A., Veenstra, D.L., Oren, E., Lee, J.K., Sadee, W.: Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA J. Am. Med. Assoc. 286(18), 2270–2279 (2001)
Percha, B., Altman, R.B.: Informatics confronts drug-drug interactions. Trends Pharmacol. Sci. 34(3), 178–184 (2013)
Samwald, M., Freimuth, R., Luciano, J.S., et al.: An RDF/OWL knowledge base for query answering and decision support in clinical pharmacogenetics. Stud. Health Technol. Inf. 192, 539–542 (2013)
Jiang, G., Solbrig, H.R., Chute, C.G.: ADEpedia: a scalable and standardized knowledge base of Adverse Drug Events using semantic web technology. In: AMIA Annual Symposium Proceedings 2011, pp. 607–616 (2011)
Jiang, G., Wang, L., Liu, H., Solbrig, H.R., Chute, C.G.: Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies. Stud. Health Technol. Inf. 192, 496–500 (2013)
Jiang, G, Liu, H.F., Solbrig, H.R., Chute, C.G.: ADEpedia 2.0: integration of normalized adverse drug events (ADEs) knowledge from the UMLS. AMIA Jt. Summits Trans. Sci. Proc. 18, 100–104 (2013)
The FDA AERS. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm. cited 4 June 2013
Wang, L., Jiang, G., Li, D., Liu, H.: Standardizing drug adverse event reporting data. Stud. Health Technol. Inf. 192, 1101 (2013)
Nelson, S.J., Zeng, K., Kilbourne, J., Powell, T., Moore, R.: Normalized names for clinical drugs: RxNorm at 6 years. J. Am. Med. Inf. Assoc. JAMIA 18(4), 441–448 (2011)
The MedDRA. http://www.meddramsso.com/. cited 16 November 2012
The CTCAE v4.0. http://evs.nci.nih.gov/ftp1/CTCAE/About.html. cited 1 June 2013
Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J., Bork, P.: A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010)
PharmGKB Dataset. http://www.pharmgkb.org/downloads.jsp. cited 8 April 2013
Tatonetti, N.P., Ye, P.P., Daneshjou, R., Altman, R.B.: Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4(125), 125 (2012)
The World Wide Web Consortium (W3C). http://www.w3.org/. cited 25 May 2013
Duke, J.D., Li, X., Grannis, S.J.: Data visualization speeds review of potential adverse drug events in patients on multiple medications. J. Biomed. Inform. 43(2), 326–331 (2010)
Ross, C.J., Visscher, H., Sistonen, J., et al.: The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. Thyroid. 20(7), 681–687 (2010)
Zhu, Q., Jiang, G., Wang, L., Chute, C.G.: Standardized drug and pharmacological class network construction. In: ICBO 2013 - Vaccine and Drug Ontology Studies (VDOS-2013) Workshop, Montreal, Qc. Canada (2013)
Acknowledgements
The study is supported in part by the SHARP Area 4: Secondary Use of EHR Data (90TR000201).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Jiang, G., Liu, H., Solbrig, H.R., Chute, C.G. (2014). Mining Severe Drug-Drug Interaction Adverse Events Using Semantic Web Technologies: A Case Study. In: Peng, WC., et al. Trends and Applications in Knowledge Discovery and Data Mining. PAKDD 2014. Lecture Notes in Computer Science(), vol 8643. Springer, Cham. https://doi.org/10.1007/978-3-319-13186-3_56
Download citation
DOI: https://doi.org/10.1007/978-3-319-13186-3_56
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13185-6
Online ISBN: 978-3-319-13186-3
eBook Packages: Computer ScienceComputer Science (R0)